A radically new approach to treat autoimmune diseases (psoriasis, RA, psoriatic arthritis, IBS, Crohn's, MS and Lupus) and cancers that evolve from chronic inflammation (liver cancer, pancreatic cancer), with an oral drug.
Recent launches
SFA002
A radically new approach to treat autoimmune diseases (psoriasis, RA, psoriatic arthritis, IBS, Crohn's, MS and Lupus) and cancers that evolve from chronic inflammation (liver cancer, pancreatic cancer), with an oral drug.
